BioFreedom US IDE Feasibility Trial

Clinical trial NCT02131142 · UNKNOWN

Trial details

NCT number: NCT02131142
Sponsor: Biosensors Europe SA
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Ischemic Heart Disease Stable Angina Unstable Angina Silent Ischemia

Start date: 2014-08-01
Primary completion: 2015-08-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.